These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9065325)

  • 1. New approaches to imaging based on effects of neurotoxins.
    Francis PT; Chessell IP; Bowen DM
    Dement Geriatr Cogn Disord; 1997; 8(2):117-22. PubMed ID: 9065325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An aspect of Alzheimer neuropathology after suicide transport damage.
    Chessell IP; Francis PT; Webster MT; Procter AW; Heath PR; Pearson RC; Bowen DM
    J Neural Transm Suppl; 1994; 44():231-43. PubMed ID: 7897395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones.
    Chessell IP; Francis PT; Pangalos MN; Pearson RC; Bowen DM
    Brain Res; 1993 Dec; 632(1-2):86-94. PubMed ID: 8149248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.
    Francis PT; Pangalos MN; Pearson RC; Middlemiss DN; Stratmann GC; Bowen DM
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1273-81. PubMed ID: 1534843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor targets on cortical pyramidal neurones as targets for Alzheimer's therapy.
    Chessell JP
    Neurodegeneration; 1996 Dec; 5(4):453-9. PubMed ID: 9117562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in cortical nicotinic acetylcholine receptor numbers following unilateral destruction of pyramidal neurones by intrastriatal volkensin injection.
    Chessell IP; Francis PT; Bowen DM
    Neurodegeneration; 1995 Dec; 4(4):415-24. PubMed ID: 8846235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of cholinergic receptors following unilateral intracortical injection of volkensin.
    Chessell IP; Pearson RC; Heath PR; Bown DM; Francis PT
    Exp Neurol; 1997 Sep; 147(1):183-91. PubMed ID: 9294415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter receptors of rat cortical pyramidal neurones: implications for in vivo imaging and therapy.
    Bowen DM; Francis PT; Pangalos MN; Chessell IP
    J Reprod Fertil Suppl; 1993; 46():131-43. PubMed ID: 8391081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of dementia and medical imaging].
    Yonekura Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1349-53. PubMed ID: 2601097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensii.
    Pangalos MN; Francis PT; Pearson RC; Middlemiss DN; Bowen DM
    J Neurosci Methods; 1991 Nov; 40(1):17-29. PubMed ID: 1795550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of neurotransmission and brain receptors in dementia.
    Pappatà S; Salvatore E; Postiglione A
    J Neuroimaging; 2008 Apr; 18(2):111-24. PubMed ID: 18380693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β.
    Maya Y; Okumura Y; Kobayashi R; Onishi T; Shoyama Y; Barret O; Alagille D; Jennings D; Marek K; Seibyl J; Tamagnan G; Tanaka A; Shirakami Y
    Brain; 2016 Jan; 139(Pt 1):193-203. PubMed ID: 26490333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic differentiation of dementia diseases by modern imaging procedures].
    Lang C; Herholz K; Huk W; Feistel H
    Fortschr Neurol Psychiatr; 1990 Oct; 58(10):380-98. PubMed ID: 2272595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Image analysis in patients with dementia].
    Tamaki N
    Hokkaido Igaku Zasshi; 1996 May; 71(3):303-7. PubMed ID: 8752524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI, CT, SPECT, PET: their use in diagnosing dementia.
    Jagust WJ; Eberling JL
    Geriatrics; 1991 Feb; 46(2):28-35. PubMed ID: 1991619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress of neuro-imaging for the diagnosis of cerebrovascular disease and dementia].
    Torizuka K
    Rinsho Hoshasen; 1989 Oct; 34(11):1355-7. PubMed ID: 2601098
    [No Abstract]   [Full Text] [Related]  

  • 19. An advance in molecular imaging of dementias.
    Albin RL
    Lancet Neurol; 2007 Apr; 6(4):288-9. PubMed ID: 17362826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dementias: present situation and future perspectives (II). Biological markers].
    Espert R; Bertolín JM; Navarro JF; González A
    Rev Neurol; 1995; 23(119):77-85. PubMed ID: 8548649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.